Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$39.1

Avg closing price
Price range

3 Stanley Druckenmiller Crinetics Pharmaceuticals Trades

Stanley Druckenmiller started to build up the position in Crinetics Pharmaceuticals in Q1 2024. Since then they sold 309 Thousand shares. The investor completely sold their stake between Q4 2024 and Q1 2025.

Avg closing price
Price range
Sold -123 Thousand shares Q1 2025
Avg closing price $37.49
Price range $32.30 - $53.15
Sold 60.3% shares (-186 Thousand shares) Q4 2024
Avg closing price $55.90
Price range $50.67 - $60.69
New holding (+309 Thousand shares) Q1 2024
Avg closing price $39.13
Price range $34.76 - $46.81

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!